FIELD: medicine; pharmacology.
SUBSTANCE: application of hydrogenated pyrido (4,3-b) indoles of the formula (1) 
or formula (2) 
as an agent possessing anxiolythic action, a pharmacological agent on its basis and a way of treatment and prevention of stresses, psychic tension, neurosises, obsessional pavors and their consequences is offered.
EFFECT: declared compounds possess expressed anxiolythic action in a conflict situation in the absence of by-effects sedative and relaxant type.
13 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GEROPROTECTING AGENT BASED ON HYDROGENATED PYRIDO[4,3-b]INDOLES (VARIANTS), PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS USING | 2003 |
|
RU2283108C2 |
| AGENT FOR TREATMENT OF ACUTE AND CHRONIC DISTURBANCES OF CEREBRAL CIRCULATION, INCLUDING STROKE ON BASIS OF HYDROGENATED PYRIDO (4,3-b)INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2340342C2 |
| AGENT FOR TREATMENT OF SCHIZOPHRENIA ON BASIS OF HYDROGENATED PYDIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2338537C2 |
| REMEDY FOR IMPROVEMENT OF COGNITIVE FUNCTIONS AND MEMORY BASED ON HYDRATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL REMEDY BASED THEREON AND METHOD OF APPLICATION THEREOF | 2006 |
|
RU2334514C1 |
| ANTIDEPRESSIVE AND ANTIHYPOXIC AGENT OF 2,8-DIMETHYL-5-[2- (6-METHYL-PYRIDYL-3)-ETHYL]-2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-b]INDOLE SALTS AND BASED PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2425046C1 |
| AGENT FOR NEUTRALISING TOXIC ACTION OF TUMOUR NECROSIS FACTOR ON BASIS OF HYDRATED PYRIDO(4,3-b)INDOLES, PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF TREATING AUTOIMMUNE DISEASE ON BASIS OF NEUTRALISING TOXIC ACTION OF TUMOUR NECROSIS FACTOR | 2012 |
|
RU2477131C1 |
| METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING ATYPICAL NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508106C2 |
| METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
| NEW APPROACH TO TREATMENT OF ALZHEIMER'S DISEASE | 1995 |
|
RU2106864C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
